Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amrubicin in advanced soft tissue sarcoma
NCT01259375Phase 2Completed
- Sponsor
- University of Utah
- Start
- Sep 2011
- Primary completion
- Feb 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of amrubicin in soft tissue sarcoma (STS), sponsored by University of Utah. Started Sep 2011; status: completed.
02
Drugs
amrubicin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01259375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259375.